Involvement of the NLRP3 inflammasome in the modulation of an LPS-induced inflammatory response during morphine tolerance

Drug and Alcohol Dependence

Volumn 132, Issue 1-2, 2013, Pages 38-46

  Mao, Xin ^a   Sarkar, Sraboni ^a   Chang, Sulie L ^a  

^a SETON HALL UNIVERSITY   (United States)

Author keywords

Chemokine; Cytokine; Morphine tolerance; NLRP3 inflammasome

Indexed keywords

BETA1 INTERFERON; CRYOPYRIN; CXCL1 CHEMOKINE; CXCL3 CHEMOKINE; GAMMA INTERFERON; INFLAMMASOME; INTERFERON; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 5; MORPHINE SULFATE; PLACEBO; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; IMMUNOMODULATION; INFLAMMATION; MALE; MORPHINE TOLERANCE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SPLEEN;

ANIMALIA; RATTUS;

CHEMOKINE; CYTOKINE; MORPHINE TOLERANCE; NLRP3 INFLAMMASOME;

ANIMALS; CARRIER PROTEINS; CHEMOKINES; CYTOKINES; DNA, COMPLEMENTARY; DRUG TOLERANCE; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MORPHINE; NARCOTICS; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED F344; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84881670121     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.12.022     Document Type: Article

References (42)

1. Allan S.M., Tyrrell P.J., Rothwell N.J. Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 2005, 5:629-640.
2. Bonnet M.P., Beloeil H., Benhamou D., Mazoit J.X., Asehnoune K. The mu opioid receptor mediates morphine-induced tumor necrosis factor and interleukin-6 inhibition in toll-like receptor 2-stimulated monocytes. Anesth. Analg. 2008, 106:1142-1149.
3. Chang S.L., Moldow R.L., House S.D., Zadina J.E. Morphine affects the brain-immune axis by modulating an interleukin-1 beta dependent pathway. Adv. Exp. Med. Biol. 1996, 402:35-42.
4. Chang S.L., Patel N.A., Romero A.A., Thompson J., Zadina J.E. FOS expression induced by interleukin-1 or acute morphine treatment in the rat hypothalamus is attenuated by chronic exposure to morphine. Brain Res. 1996, 736:227-236.
5. Chen R., Zhou H., Beltran J., Malellari L., Chang S.L. Differential expression of cytokines in the brain and serum during endotoxin tolerance. J. Neuroimmunol. 2005, 163:53-72.
6. Dostert C., Guarda G., Romero J.F., Menu P., Gross O., Tardivel A., Suva M.L., Stehle J.C., Kopf M., Stamenkovic I., Corradin G., Tschopp J. Malarial hemozoin is a Nalp3 inflammasome activating danger signal. PLoS One 2009, 4:e6510.
7. Fang H., Pengal R.A., Cao X., Ganesan L.P., Wewers M.D., Marsh C.B., Tridandapani S. Lipopolysaccharide-induced macrophage inflammatory response is regulated by SHIP. J. Immunol. 2004, 173:360-366.
8. Flores L.R., Wahl S.M., Bayer B.M. Mechanisms of morphine-induced immunosuppression: effect of acute morphine administration on lymphocyte trafficking. J. Pharmacol. Exp. Ther. 1995, 272:1246-1251.
9. Gomez-Flores R., Weber R.J. Inhibition of interleukin-2 production and downregulation of IL-2 and transferrin receptors on rat splenic lymphocytes following PAG morphine administration: a role in natural killer and T cell suppression. J. Interferon Cytokine Res. 1999, 19:625-630.
10. Graf J.A., Patel J.A., Chang S.L. Chronic exposure to morphine, but not ethanol, attenuates the expression of interleukin-1 beta converting enzyme in rat spleen. Immunol. Lett. 1997, 58:153-157.
11. Guarda G., Zenger M., Yazdi A.S., Schroder K., Ferrero I., Menu P., Tardivel A., Mattmann C., Tschopp J. Differential expression of NLRP3 among hematopoietic cells. J. Immunol. 2011, 186:2529-2534.
12. Gul H., Yildiz O., Dogrul A., Yesilyurt O., Isimer A. The interaction between IL-1beta and morphine: possible mechanism of the deficiency of morphine-induced analgesia in diabetic mice. Pain 2000, 89:39-45.
13. Guma M., Ronacher L., Liu-Bryan R., Takai S., Karin M., Corr M. Caspase 1-independent activation of interleukin-1beta in neutrophil-predominant inflammation. Arthritis Rheum. 2009, 60:3642-3650.
14. Hilburger M.E., Adler M.W., Truant A.L., Meissler J.J., Satishchandran V., Rogers T.J., Eisenstein T.K. Morphine induces sepsis in mice. J. Infect. Dis. 1997, 176:183-188.
15. Homji N.F., Mao X., Langsdorf E.F., Chang S.L. Endotoxin-induced cytokine and chemokine expression in the HIV-1 transgenic rat. J. Neuroinflam. 2012, 9:3.
16. House S.D., Mao X., Wu G., Espinelli D., Li W.X., Chang S.L. Chronic morphine potentiates the inflammatory response by disrupting interleukin-1beta modulation of the hypothalamic-pituitary-adrenal axis. J. Neuroimmunol. 2001, 118:277-285.
17. Hutchinson M.R., Coats B.D., Lewis S.S., Zhang Y., Sprunger D.B., Rezvani N., Baker E.M., Jekich B.M., Wieseler J.L., Somogyi A.A., Martin D., Poole S., Judd C.M., Maier S.F., Watkins L.R. Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia. Brain Behav. Immun. 2008, 22:1178-1189.
18. Limiroli E., Gaspani L., Panerai A.E., Sacerdote P. Differential morphine tolerance development in the modulation of macrophage cytokine production in mice. J. Leukoc. Biol. 2002, 72:43-48.
19. Mankan A.K., Dau T., Jenne D., Hornung V. The NLRP3/ASC/Caspase-1 axis regulates IL-1beta processing in neutrophils. Eur. J. Immunol. 2011, 42:710-715.
20. Martich G.D., Boujoukos A.J., Suffredini A.F. Response of man to endotoxin. Immunobiology 1993, 187:403-416.
21. Martinon F., Burns K., Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol. Cell 2002, 10:417-426.
22. Martinon F., Mayor A., Tschopp J. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 2009, 27:229-265.
23. Mayer-Barber K.D., Barber D.L., Shenderov K., White S.D., Wilson M.S., Cheever A., Kugler D., Hieny S., Caspar P., Nunez G., Schlueter D., Flavell R.A., Sutterwala F.S., Sher A. Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo. J. Immunol. 2010, 184:3326-3330.
24. Mebius R.E., Kraal G. Structure and function of the spleen. Nat. Rev. Immunol. 2005, 5:606-616.
25. Mogensen T.H. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin. Microbiol. Rev. 2009, 22:240-273.
26. Mohan S., Davis R.L., DeSilva U., Stevens C.W. Dual regulation of mu opioid receptors in SK-N-SH neuroblastoma cells by morphine and interleukin-1beta: evidence for opioid-immune crosstalk. J. Neuroimmunol. 2010, 227:26-34.
27. Ocasio F.M., Jiang Y., House S.D., Chang S.L. Chronic morphine accelerates the progression of lipopolysaccharide-induced sepsis to septic shock. J. Neuroimmunol. 2004, 149:90-100.
28. Olson J.K., Miller S.D. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 2004, 173:3916-3924.
29. Ossipov M.H., Lai J., King T., Vanderah T.W., Malan T.P., Hruby V.J., Porreca F. Antinociceptive and nociceptive actions of opioids. J. Neurobiol. 2004, 61:126-148.
30. Park J.I., Strock C.J., Ball D.W., Nelkin B.D. Interleukin-1beta can mediate growth arrest and differentiation via the leukemia inhibitory factor/JAK/STAT pathway in medullary thyroid carcinoma cells. Cytokine 2005, 29:125-134.
31. Patel N.A., Romero A.A., Zadina J.E., Chang S.L. Chronic exposure to morphine attenuates expression of interleukin-1 beta in the rat hippocampus. Brain Res. 1996, 712:340-344.
32. Porter K.J., Gonipeta B., Parvataneni S., Appledorn D.M., Patial S., Sharma D., Gangur V., Amalfitano A., Parameswaran N. Regulation of lipopolysaccharide-induced inflammatory response and endotoxemia by beta-arrestins. J. Cell. Physiol. 2010, 225:406-416.
33. Robertson S.E., Young J.D., Kitson S., Pitt A., Evans J., Roes J., Karaoglu D., Santora L., Ghayur T., Liew F.Y., Gracie J.A., McInnes I.B. Expression and alternative processing of IL-18 in human neutrophils. Eur. J. Immunol. 2006, 36:722-731.
34. Rothman R.B., Danks J.A., Jacobson A.E., Burke T.R., Rice K.C., Tortella F.C., Holaday J.W. Morphine tolerance increases mu-noncompetitive delta binding sites. Eur. J. Pharmacol. 1986, 124:113-119.
35. Roy S., Charboneau R.G., Barke R.A. Morphine synergizes with lipopolysaccharide in a chronic endotoxemia model. J. Neuroimmunol. 1999, 95:107-114.
36. Shavit Y., Wolf G., Goshen I., Livshits D., Yirmiya R. Interleukin-1 antagonizes morphine analgesia and underlies morphine tolerance. Pain 2005, 115:50-59.
37. Strowig T., Henao-Mejia J., Elinav E., Flavell R. Inflammasomes in health and disease. Nature 2012, 481:278-286.
38. Swirski F.K., Nahrendorf M., Etzrodt M., Wildgruber M., Cortez-Retamozo V., Panizzi P., Figueiredo J.L., Kohler R.H., Chudnovskiy A., Waterman P., Aikawa E., Mempel T.R., Libby P., Weissleder R., Pittet M.J. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science 2009, 325:612-616.
39. Vidal E.L., Patel N.A., Wu G., Fiala M., Chang S.L. Interleukin-1 induces the expression of mu opioid receptors in endothelial cells. Immunopharmacology 1998, 38:261-266.
40. Watanabe H., Gaide O., Petrilli V., Martinon F., Contassot E., Roques S., Kummer J.A., Tschopp J., French L.E. Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity. J. Invest. Dermatol. 2007, 127:1956-1963.
41. Yamin T.T., Ayala J.M., Miller D.K. Activation of the native 45-kDa precursor form of interleukin-1-converting enzyme. J. Biol. Chem. 1996, 271:13273-13282.
42. Zadina J.E., Kastin A.J., Harrison L.M., Ge L.J., Chang S.L. Opiate receptor changes after chronic exposure to agonists and antagonists. Ann. N. Y. Acad. Sci. 1995, 757:353-361.